HPLC法测定人参皂苷Re蛋清蛋白纳米混悬剂中的药物含量Determination of the content of ginsenoside Re in egg albumen nanosuspensions by HPLC
张雅昕,王龙,刘克非,王范,徐晖,邓意辉
ZHANG Ya-xin,WANG Long,LIU Ke-fei,WANG Fan,XU Hui,DENG Yi-hui(School of Pharmacy
摘要(Abstract):
目的建立人参皂苷Re蛋清蛋白纳米混悬剂中药物含量的测定方法。方法采用DiamonsilC18色谱柱(250 mm×4.6 mm,5μm),流动相为乙腈-体积分数为0.05%磷酸水溶液(体积比25∶75),流速1.0 mL.min-1,紫外检测波长203 nm,柱温25℃。结果在本实验条件下,制剂中辅料对药物含量的测定无干扰,人参皂苷Re质量浓度在44.40~177.6 mg.L-1内线性关系良好(r=0.999 9,n=5),药物平均加样回收率为100.1%,RSD为0.84%(n=9)。结论此方法准确可靠、简便易行、重现性好,可用于人参皂苷Re蛋清蛋白纳米混悬剂中药物含量的测定。
Objective To establish an HPLC method for the content determination of ginsenoside Re in egg albumen nanosuspensions.Methods The separation was performed with a Diamonsil C18 column(250 mm×4.6 mm,5 μm) at 25 ℃,and the mobile phase was acetonitrile-0.05% phosphoric acid(V∶V=25∶75),the flow rate was 1.0 mL·min-1 and detective wavelength was set at 203 nm.Results The linear range of ginsenoside Re was 44.40-177.6 mg·L-1(r=0.999 9,n=5).The average recovery of ginsenoside Re was 100.1%,and RSD was 0.84%(n=9).Conclusions The method is simple,accurate and reproducible,and it can be used for determination of ginsenoside Re in egg albumen nanosuspensions.
关键词(KeyWords):
人参皂苷Re;蛋清蛋白纳米混悬剂;高效液相色谱法;含量测定
ginsenoside Re;egg albumen nanosuspension;HPLC;content determination
基金项目(Foundation): 国家重点基础研究发展计划(973计划)资助项目(2009CB930300)
作者(Author):
张雅昕,王龙,刘克非,王范,徐晖,邓意辉
ZHANG Ya-xin,WANG Long,LIU Ke-fei,WANG Fan,XU Hui,DENG Yi-hui(School of Pharmacy
DOI: 10.14066/j.cnki.cn21-1349/r.2010.10.008
参考文献(References):
- [1]彭缨.人参皂苷Re及其固体分散物药物动力学研究[D].沈阳:沈阳药科大学,2001:5-7.
- [2]姜红柳,杨振,孟勤,等.人参皂苷Re对小鼠学习记忆障碍的作用[J].中国药理学通报,2008,24(10):1399-1400.
- [3]吕爽.人参皂苷Re的抗休克作用[D].沈阳:沈阳药科大学,2006:44-50.
- [4]KATTEBOINAA S,CHANDRASEKHAR V S R,BAL-AJI S.Drug nanocrystals:a novel formulation approachfor poorly soluble drugs[J].International Journal ofPharm Tech Research,2009,1(3):682-694.
- [5]EERDENBRUGH B V,MOOTER G V,AUGUSTIJINSP.Top-down production of drug nanocrystals:Nanosus-pension stabilization,miniaturization and transformationinto solid products[J].International Journal of Pharma-ceutics,2008,364:64-75.
- [6]LEE J,CHOI J Y,PARK C H.Characteristics of poly-mers enabling nano-comminution of water-insolubledrugs[J].International Journal of Pharmaceutics,2008,355:328-336.
- [7]张辉,霍美蓉,周建平.伊曲康唑白蛋白纳米混悬剂的制备和表征[J].中国药科大学学报,2008,39(6):510-514.
- [8]JUNGHANNS J U A H,M LLER R H.Nanocrystaltechnology,drug delivery and clinical applications[J].International Journal of Nanomedicine,2008,3(3):295-309.
- [9]王宁,邓意辉,王绍宁,等.高效液相色谱法测定葫芦素B人血清白蛋白纳米粒中药物含量[J].中国新药杂志,2007,16(23):1968-1970.
- [10]刘欣荣,王龙,卢懿,等.HPLC法测定羟基喜树碱人血清白蛋白纳米粒中的药物含量[J].沈阳药科大学学报,2009,26(1):48-51.